| 000 | 01850 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517051433.0 | ||
| 264 | 0 | _c20160104 | |
| 008 | 201601s 0 0 eng d | ||
| 022 | _a1521-0103 | ||
| 024 | 7 |
_a10.1124/jpet.115.226969 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPandey, Sanjay K | |
| 245 | 0 | 0 |
_aIdentification and characterization of modified antisense oligonucleotides targeting DMPK in mice and nonhuman primates for the treatment of myotonic dystrophy type 1. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cNov 2015 |
||
| 300 |
_a329-40 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMacaca fascicularis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 |
_aMuscle, Skeletal _xenzymology |
| 650 | 0 | 4 |
_aMyotonic Dystrophy _xdrug therapy |
| 650 | 0 | 4 |
_aMyotonin-Protein Kinase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aOligonucleotides _xchemistry |
| 650 | 0 | 4 |
_aOligonucleotides, Antisense _xpharmacology |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 700 | 1 | _aWheeler, Thurman M | |
| 700 | 1 | _aJustice, Samantha L | |
| 700 | 1 | _aKim, Aneeza | |
| 700 | 1 | _aYounis, Husam S | |
| 700 | 1 | _aGattis, Danielle | |
| 700 | 1 | _aJauvin, Dominic | |
| 700 | 1 | _aPuymirat, Jack | |
| 700 | 1 | _aSwayze, Eric E | |
| 700 | 1 | _aFreier, Susan M | |
| 700 | 1 | _aBennett, C Frank | |
| 700 | 1 | _aThornton, Charles A | |
| 700 | 1 | _aMacLeod, A Robert | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 355 _gno. 2 _gp. 329-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1124/jpet.115.226969 _zAvailable from publisher's website |
| 999 |
_c25223109 _d25223109 |
||